Abstract
The concept that cells subjected to chromatin cleavage during apoptosis are destined to die is being challenged. The execution phase of apoptosis is characterized by the activation of effector caspases, such as caspase-3, that cleave key regulatory or structural proteins and in particular activate apoptotic nucleases such as the caspase activated deoxyribonuclease (CAD). It is apparent that caspases of this type may become active both through non-apoptotic processing and potentially within cells that exhibit apoptotic morphology but are subsequently able to survive. In such systems caspase suppressor molecules, the inhibitors of apoptotic proteins or IAP's, may rescue cells from apoptotic nuclease(s) attack initiated by transient caspase activation. The MLL gene is involved in leukemogenic translocations in ALL and AML and is a target of nuclease cleavage during apoptosis. Translocations initiated at the site of apoptotic nuclease attack within MLL have been identified and may offer a model, with clinical relevance, for DNA damage mediated by the apoptosis system in cells destined to survive. The specificity of apoptotic cleavage combined with the potential for recovery from the execution phase of apoptosis suggests a novel and pathogenic role for apoptosis in creating translocations with leukemogenic potential.
Similar content being viewed by others
References
Ashkenazi A, Dixit VM Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999; 11: 255–260.
Robertson JD, Orrenius S Molecular mechanisms of apoptosis induced by cytotoxic chemicals. Crit Rev Toxicol 2000; 30: 609–627.
Renz A, Berdel WE, Kreuter M, Belka C, Schulze-Osthoff K, Los M Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood 2001; 98: 1542–1548.
Belka C, Schmid B, Marini P, et al. Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL. Oncogene 2001; 20: 2190–2196.
Shimizu S, Narita M, Tsujimoto Y Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999; 399: 411–412.
Burns TF, Bernhard EJ, El-Deiry WS Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo. Oncogene 2001; 20: 4601–4612.
Nishii K, Gibbons DL, Titley I, Papworth D, Goodhead DT, Greaves M Regulation of the apoptotic response to radiation damage in B cell development. Cell Death Differ 1998; 5: 77–86.
Bailly-Maitre B, de Sousa G, Boulukos K, Gugenheim J, Rahmani R Dexamethasone inhibits spontaneous apoptosis in primary cultures of human and rat hepatocytes via Bcl-2 and Bcl-xL induction. Cell Death Differ 2001; 8: 279–288.
Saintigny Y, Dumay A, Lambert S, Lopez BS A novel role for the Bcl-2 protein family: Specific suppression of the RAD51 recombination pathway. EMBO J 2001; 20: 2596–2607.
Kaufmann SH, Earnshaw WC Induction of apoptosis by cancer chemotherapy. Exp Cell Res 2000; 256: 42–49.
Earnshaw WC, Martins LM, Kaufmann SH Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999; 68: 383–424.
Slee EA, Adrain C, Martin SJ Executioner caspase-3,-6, and-7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 2001; 276: 7320–7326.
Thornberry NA, Lazebnik Y Caspases: Enemies within. Science 1998; 281: 1312–1316.
Deveraux QL, Reed JC IAP family proteins-suppressors of apoptosis. Genes Dev 1999; 13: 239–252.
Deveraux QL, Roy N, Stennicke HR IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998; 17: 2215–2223.
Datta R, Oki E, Endo K, Biedermann V, Ren J, Kufe D XIAP regulates DNA damage-induced apoptosis downstream of caspase-9 cleavage. J Biol Chem 2000; 275: 31733–31738.
Takahashi R, Deveraux Q, Tamm I, et al. A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem 1998; 273: 7787–7790.
Kannan K, Amariglio N, Rechavi G, et al. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene 2001; 20: 2225–2234.
Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J 1999; 18: 5242–5251.
Holcik M, Yeh C, Korneluk RG, Chow T Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene 2000; 19: 4174–4177.
Nagata S. Apoptotic DNA fragmentation. Exp Cell Res 2000; 256: 12–18.
Clemens MJ, Bushell M, Jeffrey IW, Pain VM, Morley SJ Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells. Cell Death Differ 2000; 7: 603–615.
Holcik M, Sonenberg N, Korneluk RG Internal ribosome initiation of translation and the control of cell death. Trends Genet 2000; 16: 469–473.
Holcik M, Lefebvre C, Yeh C, Chow T, Korneluk RG A new internal-ribosome-entry-site motif potentiates XIAPmediated cytoprotection. Nat Cell Biol 1999; 1: 190–192.
Stoneley M, Chappell SA, Jopling CL, Dickens M, MacFarlane M, Willis AE-Myc protein synthesis is initiated from the internal ribosome entry segment during apoptosis. Mol Cell Biol 2000; 20: 1162–1169.
Coldwell MJ, Mitchell SA, Stoneley M, MacFarlane M, Willis AE Initiation of Apaf-1 translation by internal ribosome entry. Oncogene 2000; 19: 899–905.
Hengartner MO Apoptosis: Corralling the corpses. Cell 2001; 104: 325–328.
Hoeppner DJ, Hengartner MO, Schnabel R Engulfment genes cooperate with ced-3 to promote cell death in Caenorhabditis elegans. Nature 2001; 412: 202–206.
Reddien PW, Cameron S, Horvitz HR Phagocytosis promotes programmed cell death in C. elegans. Nature 2001; 412: 198–202.
Meier P, Finch A, Evan G Apoptosis in development. Nature 2000; 407: 796–801.
Hammill AK, Uhr JW, Scheuermann RH Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. Exp Cell Res 1999; 251: 16–21.
Alam A, Cohen LY, Aouad S, Sekaly RP Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J Exp Med 1999; 190: 1725–1727.
Hishita T, Tada-Oikawa S, Tohyama K, et al. Caspase-3 activation by lysosomal enzymes in cytochrome c-independent apoptosis in myelodysplastic syndrome-derived cell line P39. Cancer Res 2001; 61: 2878–2884.
Ziegler A, Jonason AS, Leffell DJ, et al. Sunburn and p53 in the onset of skin cancer. Nature 1994; 372: 773–776.
Mattson MP Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 2000; 1: 120–129.
Felix CA, Winick NJ, Negrini M, Bowman WP, Croce CM, Lange BJ Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia. Cancer Res 1993; 53: 2954–2956.
Super HJ, McCabe NR, Thirman MJ, et al. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNAtopoisomerase II. Blood 1993; 82: 3705–3711.
Rubnitz JE, Behm FG, Downing JR 11q23 rearrangements in acute leukemia. Leukemia 1996; 10: 74–82.
Thandla S, Aplan PD Molecular biology of acute lymphocytic leukemia. Semin Oncol 1997; 24: 45–56.
Felix CA, Lange BJ, Hosler MR, et al. Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites. Cancer Res 1995; 55: 4287–4292.
Sim SP, Liu LF Nucleolytic cleavage of the MLL breakpoint cluster region (bcr) during apoptosis. J Biol Chem 2001 [epub ahead of print].
Betti CJ, Villalobos MJ, Diaz MO, Vaughan ATM Apoptotic triggers initiate translocations within the MLL Gene involving the nonhomologous end joining repair system. Cancer Res 2001; 61: 4550–4555.
Stanulla M, Wang J, Chervinsky DS, Thandla S, Aplan PD DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis. Mol Cell Biol 1997; 17: 4070–4079.
Eguchi-Ishimae M, Eguchi M, Ishii E, et al. Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals. Blood 2001; 97: 737–743.
Uckun FM, Herman-Hatten K, Crotty ML, et al. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. Blood 1998; 92: 810–821.
Strissel PL, Strick R, Tomek RJ, et al. DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. Hum Mol Genet 2000; 9: 1671–1679.